What is Pipeline Rx?
Pipeline Rx specializes in delivering advanced pharmacy and telepharmacy services tailored for community hospitals, multi-facility health systems, and specialized healthcare facilities. Their comprehensive service portfolio includes clinical telepharmacy, transitions of care management, and patient therapy management systems, all designed to optimize pharmacy operations through technological integration and expert knowledge. By focusing on improving patient outcomes and reducing healthcare costs, Pipeline Rx supports a wide array of care settings, from surgery centers to long-term care facilities, ensuring efficient and high-quality medication management.
How much funding has Pipeline Rx raised?
Pipeline Rx has raised a total of $18.6M across 4 funding rounds:
Private Equity
$2.4M
Other Financing Round
$5M
Private Equity
$9.2M
Debt
$2M
Private Equity (2014): $2.4M with participation from AMN Healthcare Services
Other Financing Round (2014): $5M led by AMN Healthcare
Private Equity (2015): $9.2M supported by McKesson, Mitsui & Co. (U.S.A.), Inc., and AMN Healthcare
Debt (2020): $2M featuring PPP
Key Investors in Pipeline Rx
McKesson
McKesson Corporation is a global leader in healthcare supply chain management solutions, pharmaceuticals, and medical supplies. Their investment in Pipeline Rx likely signifies a strategic alignment in enhancing pharmacy operations and distribution networks within the broader healthcare ecosystem.
Mitsui & Co. (U.S.A.), Inc.
Mitsui & Co. is a global trading and investment company with a diverse portfolio. Their participation suggests an interest in Pipeline Rx's role within the healthcare sector and its potential for growth and innovation in pharmacy services.
AMN Healthcare
AMN Healthcare is a leading total talent solutions provider for healthcare organizations. Their investment in Pipeline Rx indicates a strategic focus on integrated healthcare services and talent management within the pharmacy sector.
What's next for Pipeline Rx?
The recent major strategic investment signals a pivotal phase for Pipeline Rx, likely enabling accelerated expansion of its service offerings and technological capabilities. This capital infusion is expected to bolster the company's market penetration, potentially through strategic partnerships or acquisitions, and further enhance its telepharmacy platform. Pipeline Rx is positioned to leverage this financing to solidify its leadership in optimizing pharmacy operations and patient therapy management across diverse healthcare environments, driving innovation and efficiency in medication delivery.
See full Pipeline Rx company page
